Birmingham Hematology & Oncology Associates, LLC, where Dr. Vance is a physician, partner, and Vice-President, purchased medical professional liability insurance from a ProAssurance insurance subsidiary.
| Officer | Age | 2024 pay | Source |
|---|---|---|---|
|
Edward L. Rand, Jr.
Also a director
President & CEO
Title from the Form 4 dated Jun 26, 2026
|
58 | $6,226,834 | |
|
Dana S Hendricks
Chief Financial Officer
Title from the Form 4 dated Jun 26, 2026
|
Not stated | $2,049,595 | |
|
Noreen Dishart
Executive VP/Chief HR Officer
Title from the Form 4 dated Jun 26, 2026
|
Not stated | Not reported | |
|
Kevin Merrick Shook
President of a Subsidiary
Title from the Form 4 dated Jun 26, 2026
|
Not stated | $1,790,417 | |
|
Robert David Francis
Pres Healthcare Pro. Liability
Title from the Form 4 dated Jun 26, 2026
|
Not stated | $2,415,135 | |
|
Jeffrey Patton Lisenby
Executive Vice-President
Title from the Form 4 dated Jun 26, 2026
|
Not stated | $2,087,357 |
Each officer opens the passage of the filing that names them. A title that changed since the list comes from the officer's latest Form 3, 4 or 5, and its start year is not stated there. "Not stated" means the filing does not say. Pay is the proxy's Summary Compensation Table, which reports only the named executive officers.
From the proxy statement filed Apr 11, 2025 · updated by the 8-Ks of May 21, 2025 and Jun 26, 2026
| Director | Age | On board | Committees | Other public boards | 2024 pay | Source |
|---|---|---|---|---|---|---|
|
Bruce D. Angiolillo
Board chair
|
72 |
2016
9 years
|
None stated | None stated | $383,809 | |
|
Edward L. Rand, Jr.
CEO
|
58 |
2019
6 years
|
None stated | None stated | Paid as CEO | |
|
Samuel A. Di Piazza, Jr.
|
74 |
2014
11 years
|
None stated | Warner Bros. Discovery Inc. | $289,017 | |
|
Maye Head Frei
|
54 |
2019
6 years
|
None stated | None stated | $296,059 | |
|
Scott C. Syphax
|
61 |
2021
4 years
|
None stated | None stated | $283,809 | |
|
Fabiola Cobarrubias, M.D.
|
58 |
2021
4 years
|
None stated | None stated | $296,309 | |
|
Katisha T. Vance, M.D.
|
50 |
2017
8 years
|
None stated | None stated | $293,809 | |
|
Richard J. Bielen, C.P.A.
|
64 | Not stated |
Audit Committee · Chair
|
None stated | $148,958 | |
|
Staci M. Pierce
|
49 | Not stated | None stated | None stated | $141,667 | |
|
Samuel A. DiPiazza, Jr.
Joined May 21, 2025
|
- | - | - | - | - | |
|
Robert E. White, Jr.
Joined Jun 26, 2026
|
- | - | - | - | - | |
|
Marco Vanderlaan
Joined Jun 26, 2026
|
- | - | - | - | - | |
|
David A. McHale
Joined Jun 26, 2026
|
- | - | - | - | - |
Each director opens the passage of the proxy that names them. "Not stated" means the proxy does not say; it never means "no". Pay is the proxy's Director Compensation table; the CEO is paid as an executive. A director marked Joined was added by an 8-K; their row opens that 8-K, and a dash is a value it does not give.
Birmingham Hematology & Oncology Associates, LLC, where Dr. Vance is a physician, partner, and Vice-President, purchased medical professional liability insurance from a ProAssurance insurance subsidiary.
Pacific Inpatient Medical Group, where Dr. Cobarrubias is the Chief Executive Officer, purchased medical professional liability insurance from a ProAssurance insurance subsidiary.
Loading...